Opioid Rehab Cost in Texas: Treatment, Coverage Gap, and 2026 Pricing
Opioid rehab in Texas costs $15,000 to $55,000 for a 30-day inpatient program without insurance, or $6,000 to $20,000 out-of-pocket with PPO insurance. Texas has 46% fentanyl involvement in opioid overdoses (TX DSHS 2023) with rising trend — driven by border trafficking through the Rio Grande Valley, I-35 corridor distribution, and counterfeit pressed pill prevalence. Texas has the nation’s highest uninsured rate at 16.7% with 1.4 million adults in the Medicaid coverage gap. The OSAR system (1-877-541-7905) provides free OUD treatment for the coverage gap across all 11 HHSC regions.
Texas faces a unique opioid challenge: a fentanyl trafficking corridor with the nation’s worst coverage profile. The state’s preliminary 2024 data show 12% decline from the 2023 peak — reflecting expanded OSAR capacity, Opioid Settlement Fund deployment ($1.5B+ over 18 years), naloxone distribution, and telehealth buprenorphine expansion. This guide combines Texas’s 2020–2026 policy infrastructure (OSAR, Opioid Abatement Fund, behavioral telehealth) with OUD-specific clinical protocols (Bernese induction, ED-bup bridges, long-acting MAT) and the coverage-gap reality affecting 1.4 million Texans.
Texas’s Opioid Reality: 46% Fentanyl, Rising
Texas DSHS 2023 data show fentanyl involved in approximately 46% of Texas opioid overdoses — lower than coastal states (FL 78%, NY 80%, CA 71%) but rising rapidly. Key drivers:
- Border trafficking. 1,254-mile U.S.-Mexico border; fentanyl crossings concentrated in Rio Grande Valley (Hidalgo, Cameron, Webb), Laredo, and El Paso
- I-35 distribution corridor. Laredo-San Antonio-Austin-Dallas-Fort Worth
- Gulf Coast ports. Houston as distribution hub
- Counterfeit pressed pills. Fake Percocet, Xanax, Adderall increasingly prevalent in Texas border and I-35 markets
- Xylazine contamination rising but lower than Northeast (~10–15% regional estimate)
Preliminary 2024 Decline
TX DSHS preliminary data indicate 2024 overdose deaths declined approximately 12% from the 2023 peak of 5,687. Possible contributors: naloxone saturation, Opioid Settlement Fund deployment, expanded MAT access post-2023 X-waiver elimination, telehealth buprenorphine, OSAR capacity expansion.
Clinical Implications
- Longer detox. 7–10 days for fentanyl-contaminated OUD
- Bernese induction preferred at TX academic medical centers
- Long-acting MAT. Brixadi weekly, Sublocade monthly for fentanyl-era retention
- Multiple naloxone doses (4–8 mg) for fentanyl-contaminated overdose
For fentanyl-specific mechanics, see fentanyl rehab cost in Texas.
Why Texas Is Different for Opioid Treatment
1. 16.7% Uninsured Rate (Nation’s Highest)
Nation-high uninsured rate affects OUD access profoundly. OSAR is the primary bridge.
2. 1.4 Million Medicaid Coverage Gap
TX did not expand Medicaid. Managing the largest coverage gap in the nation requires OSAR + marketplace + faith-based + Cenikor + FQHCs.
3. OSAR System (11 HHSC Regions)
Free/sliding-scale OUD treatment pathway including MAT across the entire state.
4. Texas Opioid Settlement Fund ($1.5B+)
18-year deployment for MAT expansion, harm reduction, mobile OTPs, rural capacity, OSAR expansion.
5. Border Fentanyl Trafficking
Unique geographic challenge. Border health departments face bilingual service needs, transportation barriers, and limited specialty addiction medicine capacity.
6. Behavioral Telehealth Expansion
Texas Medicaid has prioritized behavioral telehealth — one of the most utilized services. Telehealth buprenorphine has expanded rural access.
7. 90+ OTPs + Low-Cost Methadone
Texas OTP methadone rates are among the lowest in the nation at $250–$500/month self-pay.
For full Texas regulatory context, see rehab cost in Texas. For opioid-specific clinical treatment nationally, see opioid rehab cost.
Opioid Rehab Cost in TX: 2026 Breakdown
| Level of Care | Duration | Without Insurance | With PPO |
|---|---|---|---|
| Medical detox (pure opioid) | 5–7 days | $1,750 – $4,900 | $700 – $2,500 |
| Medical detox (fentanyl-contaminated) | 7–10 days | $2,500 – $7,000 | $1,000 – $3,500 |
| Inpatient residential (community) | 30 days | $15,000 – $25,000 | $6,000 – $12,000 |
| Inpatient residential (mid-tier) | 30 days | $25,000 – $40,000 | $10,000 – $18,000 |
| Houston / Dallas luxury | 30 days | $40,000 – $100,000+ | Capped at OOP max |
| Partial hospitalization (PHP) | 4–6 weeks | $4,000 – $14,000 | Capped at OOP max |
| Intensive outpatient (IOP) | 8–12 weeks | $3,000 – $10,000 | Capped at OOP max |
| MAT ongoing | 12–24+ months | $200 – $1,700/month | $25 – $200/month |
Texas’s OUD Geography
Urban OUD
- Houston metro: 25+ OTPs, largest TX treatment market, luxury options
- Dallas-Fort Worth: 20+ OTPs, strong mid-tier
- San Antonio: 10+ OTPs
- Austin: 8+ OTPs, growing tech-forward treatment
- El Paso: 6+ OTPs, border trafficking proximity
Rural OUD Crisis
- Panhandle, West Texas (few local OTPs; 200+ mile travel for residential)
- Rio Grande Valley (uninsured concentration, bilingual needs)
- East Texas (Teen Challenge and Salvation Army coverage)
- South Texas border (limited specialty capacity)
Federal mobile OTP regulatory updates (2024) + Opioid Settlement Fund + telehealth buprenorphine are expanding rural access but gaps remain substantial.
MAT Economics in Texas
Seven FDA-approved opioid MAT approaches are covered by Texas commercial plans and TX Medicaid.
| Medication | Mechanism | TX Self-Pay (Monthly) | TX Insured (Monthly) | TX Medicaid |
|---|---|---|---|---|
| Generic buprenorphine/naloxone | Partial agonist | $350 – $750 | $25 – $200 | $0 – $5 |
| Suboxone brand | Partial agonist | $400 – $600 | $25 – $150 | $0 – $5 |
| Sublocade (monthly) | Long-acting bup | $1,600 – $1,800 | $50 – $300 | $0 – $10 |
| Brixadi (weekly or monthly) | Long-acting bup | $600 – $1,800 | $50 – $350 | $0 – $10 |
| Methadone (OTPs) | Full agonist | $250 – $500 | $50 – $200 | $0 |
| Vivitrol (monthly injection) | Antagonist | $1,300 – $1,700 | $0 – $300 | $0 – $10 |
| Oral naltrexone | Antagonist | $50 – $150 | $10 – $50 | $0 – $3 |
Choosing MAT in Texas
- Generic buprenorphine (Suboxone): First-line; office-based prescribing; lowest cost; telehealth available
- Brixadi weekly: Fentanyl-era preference — tight dosing, no daily adherence pressure
- Sublocade monthly: For stable patients with compliance concerns
- Methadone (OTPs): Severe OUD; 90+ TX OTPs concentrated in metros; lowest-cost methadone rates
- Vivitrol: Requires 7–14 days opioid-free; for patients with legal/employment reasons
Bernese Low-Dose Buprenorphine Induction in Texas
Bernese protocols are preferred for fentanyl-contaminated OUD at major TX academic medical centers.
Protocol Timeline
| Day | Bup Dose | Status |
|---|---|---|
| 1 | 0.5 mg | Continues fentanyl use |
| 2 | 1.0 mg | Continues fentanyl use |
| 3 | 2.0 mg | Begins reducing fentanyl |
| 4 | 4.0 mg | Further reduces fentanyl |
| 5 | 8.0 mg | Discontinues fentanyl |
| 6–7 | 12–16 mg | Titrate to therapeutic dose |
TX Facilities Using Bernese Induction
- UT Southwestern (Dallas) — academic addiction medicine
- Baylor Scott & White (multiple locations) — hospital system
- UTMB Galveston — academic
- Dell Medical School UT Austin — academic
- UT Health San Antonio — academic
- UT Health Houston — academic
- Houston Methodist — hospital system
- Memorial Hermann / TIRR Memorial Hermann — Houston
- Parkland (Dallas public) — academic/safety net
- Growing number of community residential providers
Ask facilities directly.
ED-Initiated Buprenorphine Bridges at TX Hospitals
Major TX hospitals have developed ED-bup bridge programs:
- UT Southwestern (Dallas)
- Parkland Health (Dallas public)
- Baylor Scott & White System
- UTMB Galveston
- Houston Methodist
- Memorial Hermann
- Dell Seton Medical Center (Austin)
- UT Health San Antonio
- University Medical Center (El Paso)
Research (JAMA 2023) shows dramatic improvements in 6-month retention. Ask in the ED: “Is there an ED-initiated buprenorphine bridge program?”
Texas Opioid Settlement Fund Deployment
Texas’s $1.5B+ settlement share over 18 years is dedicated to:
- MAT expansion in underserved counties (Panhandle, Rio Grande Valley, West TX)
- Naloxone distribution through TX DSHS
- Mobile OTP services for rural counties
- Telehealth buprenorphine expansion
- Workforce development for addiction medicine
- OSAR capacity expansion
- Residential OUD treatment expansion
- ED-bup bridge program expansion
Texas Opioid Abatement Fund Council manages allocation.
How Do Texans Afford Opioid Rehab?
1. Texas Medicaid (Restricted Eligibility)
Pregnant women, children, low-income parents, elderly, disabled. Full OUD continuum at $0 through managed care plans.
2. Private Commercial Insurance
BCBSTX, UHC, Aetna, Cigna, Humana, Ambetter/Superior, Molina. Capped at $7,000–$9,500 OOP max.
3. OSAR System (1.4M Coverage Gap)
Call 1-877-541-7905 or 211. Free or sliding-scale OUD treatment.
4. Healthcare.gov Marketplace
Subsidized plans. Premiums $30–$450/month.
5. Cenikor Foundation
Nonprofit long-term residential (6–12 months) in Houston and Fort Worth.
6. Faith-Based Free Residential
Salvation Army ARCs (7+ TX cities), Teen Challenge Texas, Victory Outreach.
7. 72 FQHCs (Most of Any State)
Sliding fee scale OUD treatment.
Choosing a Texas Opioid Rehab
Verification questions before admission:
- Is the facility HHSC-licensed?
- Is the facility accredited (Joint Commission, CARF, COA)?
- Is the facility in-network for my plan?
- Do you offer low-dose (Bernese) buprenorphine induction?
- Is Brixadi weekly injection on formulary?
- What’s the MAT continuation plan at discharge?
- Are you an OSAR-contracted provider (if coverage-gap)?
- Do you offer telehealth buprenorphine continuation (relevant for rural)?
- What’s my deductible and OOP max, and what’s met year-to-date?
Texas Opioid Resources
State Resources
- Texas OSAR: 1-877-541-7905
- TX HHSC Substance Use: hhs.texas.gov
- TX DSHS: dshs.texas.gov
- SAMHSA National Helpline: 1-800-662-4357
- 988 Suicide & Crisis Lifeline: 988
- YourTexasBenefits (Medicaid): yourtexasbenefits.com
- Healthcare.gov Texas: healthcare.gov
Harm Reduction
- TX DSHS Naloxone Distribution — free naloxone
- Texas Good Samaritan Law (limited — consult attorney)
- Fentanyl Test Strip Distribution — through TX DSHS-funded programs
Major TX Cities
- Houston: 211
- Dallas-Fort Worth: 211
- San Antonio: 211
- Austin: 211
- El Paso: 211
- Rio Grande Valley (Hidalgo, Cameron, Webb): 211
Success Rate Reality
Opioid use disorder recovery rates depend on MAT continuation:
- With MAT for 12+ months: 40–60% sustained recovery
- Without MAT: 10–30%
- MAT reduces overdose-death risk by ~50% (NIDA)
- Treatment retention 2–4x higher on MAT
Recovery is a chronic-disease process. Most OUD patients need multiple treatment episodes.
Final Thoughts
Texas’s opioid treatment challenge is the combination of border fentanyl trafficking and the nation’s highest uninsured rate. The OSAR system, Texas Opioid Settlement Fund deployment ($1.5B+), Cenikor Foundation, Salvation Army ARCs, 72 FQHCs, and Texas Medicaid behavioral telehealth expansion collectively build functional access — but gaps remain severe in rural Panhandle, West Texas, and the border region.
Five steps:
- Check TX Medicaid eligibility — restrictive but covers fully if eligible
- If in coverage gap: Call OSAR 1-877-541-7905
- Consider Cenikor or Salvation Army ARC for free long-term residential
- Ask about low-dose induction + Brixadi at admitting facility
- Use ED-bup bridge if in an ED after overdose
For broader context, see rehab cost in Texas, opioid rehab cost, fentanyl rehab cost, medical detox cost, and does insurance cover rehab.
Sources
- Texas Department of State Health Services. “Overdose Data to Action.” 2023.
- Texas Health and Human Services Commission. “OSAR System.” 2024.
- Texas Opioid Abatement Fund Council. “Allocation Priorities.” 2024.
- U.S. Census Bureau. “American Community Survey.” 2024.
- Drug Enforcement Administration. “National Drug Threat Assessment.” 2024.
- Consolidated Appropriations Act of 2023. “DATA 2000 X-Waiver Elimination.”
- D’Onofrio G, et al. “Emergency Department–Initiated Buprenorphine.” JAMA. 2023.
- Randhawa PA, et al. “Buprenorphine Low-Dose Induction (Bernese Method).” Journal of Addiction Medicine. 2024.
- National Institute on Drug Abuse. “Medications to Treat Opioid Use Disorder Research Report.” 2024.
- American Society of Addiction Medicine. “Clinical Practice Guideline for the Treatment of Opioid Use Disorder.” 2020.
- U.S. Department of Labor. “Mental Health Parity and Addiction Equity Act Final Rule (September 2024).”
- Dallas Federal Reserve. “Southwest Economy: Opioid Crisis Analysis.” 2025.
- SAMHSA Behavioral Health Treatment Services Locator. 2025. https://findtreatment.samhsa.gov/
Opioid Treatment in Texas — Is Your Plan Enough?
Even with insurance, many people discover their plan doesn't cover residential treatment at the level they need. A broker who specializes in behavioral health coverage can review your situation and find a plan that works.
Call 1-866-454-9577Free Consultation · No Obligation
Prodest Insurance Group is a licensed, independent health insurance brokerage. Calling the number above connects you with a licensed insurance agent, not a treatment facility. Insurance placement is a separate service from treatment referral.
Frequently Asked Questions
How much does opioid rehab cost in Texas?
Opioid rehab in Texas costs $15,000–$55,000 for 30 days of inpatient treatment without insurance, or $6,000–$20,000 out-of-pocket with PPO insurance (capped at the 2026 OOP max of $7,000–$9,500). Medical detox adds $1,750–$7,000 (7–10 days — longer than pure-opioid protocols because 46% of Texas opioid overdoses involve fentanyl, often requiring low-dose Bernese buprenorphine induction). Ongoing MAT runs $25–$200/month insured; $200–$1,700 self-pay. Texas Medicaid covers OUD treatment at $0 for eligible enrollees; the OSAR system (1-877-541-7905) provides free or sliding-scale treatment for the 1.4 million Texans in the Medicaid coverage gap across all 11 HHSC regions.
Does Texas Medicaid cover Suboxone?
Yes for eligible Texas Medicaid beneficiaries. Texas Medicaid covers generic buprenorphine/naloxone (Suboxone generic) and brand Suboxone at $0–$5 per month through managed care plans (Blue Cross Blue Shield of Texas, Superior HealthPlan, Molina, UnitedHealthcare Community Plan, Aetna Better Health). Texas Medicaid also covers Sublocade monthly injection, Brixadi weekly/monthly injection, methadone through 90+ certified OTPs, Vivitrol, and oral naltrexone at minimal or no copay. Texas Medicaid eligibility is restrictive (no Medicaid expansion) — covered populations include pregnant women, children, low-income parents, elderly, and disabled. Since the 2023 federal X-waiver elimination, any TX-licensed prescriber can initiate buprenorphine. Texas Medicaid has prioritized behavioral telehealth (one of the most utilized services) — expanding rural buprenorphine access.
What is the Texas OSAR system?
OSAR (Outreach, Screening, Assessment and Referral) is Texas Health and Human Services Commission's gateway to publicly-funded SUD treatment, serving all 11 HHSC regions. OSAR provides: free screening and assessment using ASAM criteria, referral to appropriate level of care, access to state-funded outpatient and residential programs, medication-assisted treatment (Suboxone, methadone, Vivitrol), and case management and peer support. OSAR is especially critical for Texas's 1.4 million Medicaid coverage-gap adults and the 16.7% uninsured rate (nation's highest). Each HHSC region has designated OSAR providers embedded in Local Mental Health Authorities (LMHAs) and Local Behavioral Health Authorities (LBHAs), ensuring statewide coverage including rural areas (Panhandle, Rio Grande Valley, West TX, East TX). Access: call 1-877-541-7905, dial 2-1-1, or text zip code to 898211.
How long does opioid detox take in Texas?
Opioid detox in Texas typically takes 7–10 days — longer than the 5–7 days historically seen for pure heroin or prescription opioids because approximately 46% of TX opioid overdoses involve fentanyl (TX DSHS 2023). Withdrawal symptoms begin 6–12 hours after last use, peak on days 2–3 for pure opioids or days 2–5 for fentanyl-contaminated, and largely resolve by day 7–10. Post-acute withdrawal symptoms (PAWS — mood changes, sleep disruption, cravings) persist weeks to months. Many Texas academic medical centers (UT Southwestern, Baylor Scott & White, UTMB Galveston, Dell Medical School UT Austin, UT Health San Antonio) now use low-dose (Bernese) buprenorphine induction specifically because traditional COWS-threshold induction causes precipitated withdrawal in fentanyl-contaminated patients. Ask facilities directly whether Bernese protocols are available.
Is there fentanyl in Texas's opioid supply?
Yes, and the rate is rising. Texas DSHS 2023 data show fentanyl involved in approximately 46% of Texas opioid overdoses — lower than coastal states (FL 78%, NY 80%, CA 71%) but rising rapidly. Texas's geographic position makes it a major fentanyl trafficking corridor: the I-35 corridor (San Antonio to Dallas), the Rio Grande Valley border (Hidalgo, Cameron, Webb counties), and the Gulf Coast port areas (Houston) are key distribution points. Counterfeit pressed pills (fake Percocet, Xanax, Adderall) containing fentanyl are increasingly common. Xylazine contamination of the TX fentanyl supply is rising but remains lower than Northeast states (~10–15% regional estimate). Preliminary 2024 data show Texas overdose deaths declined 12% from the 2023 peak — possibly reflecting expanded naloxone saturation, Opioid Settlement Fund deployment, and MAT access improvements.
What is Texas's Opioid Settlement Fund?
The Texas Opioid Settlement Fund consists of approximately $1.5 billion+ in multi-state settlement proceeds from litigation against pharmaceutical distributors (AmerisourceBergen, Cardinal Health, McKesson), manufacturers (Purdue Pharma, Johnson & Johnson, Teva, Allergan), and pharmacies (CVS, Walgreens, Walmart). Distribution over 18 years is dedicated to addiction treatment, harm reduction, prevention, and recovery services under Texas statute. Texas Opioid Abatement Fund Council manages allocation. Deployment priorities include: MAT expansion in underserved counties (Panhandle, Rio Grande Valley, West TX); naloxone distribution through TX DSHS; mobile OTP services for rural counties; telehealth buprenorphine expansion; workforce development for addiction medicine; OSAR capacity expansion; residential OUD treatment expansion. The Fund has contributed to Texas's preliminary 2024 overdose decline.
Where are Texas's opioid treatment programs (OTPs)?
Texas has 90+ certified opioid treatment programs (OTPs) dispensing methadone, concentrated in major metropolitan areas. Distribution: Houston metro — approximately 25 OTPs; Dallas-Fort Worth — approximately 20; San Antonio — approximately 10; Austin — approximately 8; El Paso — approximately 6; Rio Grande Valley — approximately 5; rest of state — approximately 15. Rural counties face severe OTP access gaps. Federal regulatory updates in 2024 expanded mobile OTP services — deployment into rural TX is in progress with Opioid Settlement Fund support. Methadone costs: $250–$500/month self-pay at TX OTPs (lowest rates in nation); $50–$200/month insured; $0 for Texas Medicaid enrollees. Daily dispensing initially with take-home privileges after stability. For nearest OTP, use SAMHSA OTP locator at [findtreatment.samhsa.gov](https://findtreatment.samhsa.gov/).
How does border fentanyl trafficking affect Texas OUD?
Texas shares the longest U.S.-Mexico border of any state (1,254 miles), and fentanyl trafficking through Mexico — primarily from cartel production using precursor chemicals sourced from overseas — flows through Texas border crossings and distribution hubs. Key trafficking geography: Rio Grande Valley (Hidalgo, Cameron, Webb counties) for entry; I-35 corridor (Laredo-San Antonio-Austin-Dallas) for distribution; Gulf Coast ports (Houston) for broader national distribution. Counterfeit pressed pills (fake Percocet, Xanax, Adderall) are particularly prevalent in Texas border and I-35 communities. DEA has made major trafficking seizures in Texas but supply remains robust. Texas border health departments face unique challenges: large uninsured population, bilingual service needs, transportation barriers, and limited specialty addiction medicine capacity. OSAR regional services in the Rio Grande Valley (Region 11) are critical access points.
What is Bernese low-dose buprenorphine induction?
Bernese low-dose (micro-dose) buprenorphine induction is a protocol that starts buprenorphine at very low doses (0.5 mg) while the patient is still using a full opioid agonist like fentanyl, then gradually titrates up over 5–7 days before discontinuing the full agonist. This avoids precipitated withdrawal — a dangerous complication that occurs when traditional COWS-threshold induction is attempted in patients with high fentanyl tissue load. Because fentanyl is fat-soluble and accumulates in body tissues, fentanyl-contaminated opioid users often experience precipitated withdrawal with traditional induction even when they appear clinically withdrawn. Bernese protocols are now preferred at Texas academic medical centers: UT Southwestern (Dallas), Baylor Scott & White (multiple), UTMB Galveston, Dell Medical School UT Austin, UT Health San Antonio, UT Health Houston, Houston Methodist, and a growing number of community residential providers.